Welcome to InoCardia Ltd - The Contractility Company
InoCardia is a contract research organisation that specialises in novel, clinically relevant, non-clinical stage assays to assess drug effects on the contractility of the heart. Our assays are more predictive of risk in man than other in vitro models and have a greater throughput. The assays are used to identify adverse effects in humans and to test for undesirable effects of new therapeutics in early stage R&D. An accurate and cost effective way to identify cardiovascular contractility associated drug/chemical effects.